The beginning of a decline in breast cancer incidence in Italy?

Tumori

Volumn 94, Issue 3, 2008, Pages 293-296

  Zanetti, Roberto ^a   Ponti, Antonio ^a,b   Rosso, Stefano ^a   Ricceri, Fulvio ^a   Pitarella, Sabina ^a   Segnan, Nereo ^a  

^a Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica   (Italy)

^b CPO Piedmont   (Italy)

Author keywords

Breast cancer; Epidemiology; Hormone replacement therapy; Incidence rates; Mammography screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CONFIDENCE INTERVAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; ITALY; MAJOR CLINICAL STUDY; SCREENING; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 48249083044     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400301     Document Type: Article

References (21)

1. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA: The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med, 356: 1670-1674, 2007.
2. Clarke CA, Glaser SL, Uratsu CS, Selby JV Kushi LH, Herrinton LJ: Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol, 24: e49-e50, 2006.
3. Hersh AL, Stefanick ML, Stafford RS: National use of post-menopausal hormone therapy. Annual trends and response to recent evidence. JAMA, 291: 47-53, 2004.
4. Jemal A, Ward E, Thun MJ: Recent trends in breast cancer incidence rates by age and tumor characteristic among US women. Breast Cancer Res, 9: R28, 2007.
5. Breen N, A Cronin K, Meissner HI, Taplin SH, Tangka FK, Tiro JA, McNeel TS: Reported drop in mammography. Is this cause for concern? Cancer, 109: 2405-2409, 2007.
6. Cady B, Chung MA, Michaelson JS: A decline in breast-cancer incidence. New Engl J Med, 357: 511, 2007.
7. Ponti A, Rosso S, Zanetti R, Ricceri F, Tomatis M, Segnan N: Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst, 99: 1817-1818, 2007.
8. Giordano L, Giorgi D, Fasolo G, Segnan N, Del Turco MR: Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (GISMa). Tumori, 82: 31-37, 1996.
9. Curado MP Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (Eds): Cancer incidence in five continents, vol 9. Lyon: IARC, 2007. IARC Scientific Publications No. 160.
10. Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 19: 335-351, 2000.
11. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA, and National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst, 99: 1335-1339, 2007.
12. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288: 321-333, 2002.
13. Glass AG, Lacey JV, Carreon JD, Hoover RN: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst, 99: 1152-1161, 2007.
14. Beral V and Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362: 419-427, 2003.
15. Morabia A, Costanza MC: Recent reversal of trends in hormone therapy use in a European population. Menopause, 13: 111-115, 2006.
16. L'uso dei farmaci in Italia, rapporto nazionale (anni 2003-2007). Roma: Ministero della Salute, Osservatorio Nazionale sull'Impiego dei Medicinali, http://www.aifa.gov.it/section8983.html (Accessed March 20, 2008).
17. Chiaffarino F, Parazzini F, La Vecchia C, Bianchi MM, Benzi G, Ricci E, ChianteraV: Correlates of hormone replacement therapy use in Italian women. Maturitas, 33: 107-115, 1999.
18. Møller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M, Haldorsen T: The influence of mammography screening on national trends in breast cancer incidence. Eur J Cancer Prev, 14: 117-128, 2005.
19. Svendsen AL, Olsen AH, von Euler-Chelpin M, Lynge E: Breast cancer incidence after the introduction of mammography screening. What should be expected? Cancer, 106: 1883-1890, 2006.
20. Weiss NS: Breast cancer trends. Epidemiology, 18: 284, 2007.
21. MacMahon B, Cole P: Is the incidence of breast cancer declining? Epidemiology, 19(2): 268-269, 2008.